Package 13668-594-87

Brand: aprepitant

Generic: aprepitant
NDC Package

Package Facts

Identity

Package NDC 13668-594-87
Digits Only 1366859487
Product NDC 13668-594
Description

1 KIT in 1 DOSE PACK (13668-594-87) * 2 CAPSULE in 1 BLISTER PACK * 1 CAPSULE in 1 BLISTER PACK

Marketing

Marketing Status
Marketed Since 2020-10-21
Brand aprepitant
Generic aprepitant
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"spl_id": "13e87c01-b873-4d28-a5b3-3a51e49d4dd9", "openfda": {"nui": ["N0000010262", "N0000175786", "N0000182141", "N0000185507", "N0000185506"], "unii": ["1NF15YR6UY"], "rxcui": ["403810", "403811", "644088", "754508"], "spl_set_id": ["af9b6086-4bf2-472c-8740-4134eaaebace"], "pharm_class_epc": ["Substance P/Neurokinin-1 Receptor Antagonist [EPC]"], "pharm_class_moa": ["Neurokinin 1 Antagonists [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A4 Inducers [MoA]"], "manufacturer_name": ["Torrent Pharmaceuticals Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 KIT in 1 DOSE PACK (13668-594-87)  *  2 CAPSULE in 1 BLISTER PACK *  1 CAPSULE in 1 BLISTER PACK", "package_ndc": "13668-594-87", "marketing_start_date": "20201021"}], "brand_name": "APREPITANT", "product_id": "13668-594_13e87c01-b873-4d28-a5b3-3a51e49d4dd9", "dosage_form": "KIT", "product_ndc": "13668-594", "generic_name": "APREPITANT", "labeler_name": "Torrent Pharmaceuticals Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "APREPITANT", "application_number": "ANDA211835", "marketing_category": "ANDA", "marketing_start_date": "20201021", "listing_expiration_date": "20261231"}